Mandate

Vinge advises Smart Eye in connection with a capital procurement of MSEK 220

November 01, 2021 Capital Markets and Public M&A

Vinge has advised Smart Eye Aktiebolag in connection with a directed new issue of shares to Swedish and international investors that contributed MSEK 220 to Smart Eye.

The subscription price of SEK 183 SEK, which corresponded to the closing price on Nasdaq First North Growth Market, was determined through an accelerated book-building procedure arranged by Carnegie. The proceeds will primarily be used to finance the acquisition of iMotions A/S, which was published on the same day.

Vinge’s team primarily consisted of Anders StridEdin AgicOscar Lunde and Adrian Filipovic.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026